Ketoconazole + Abiraterone Acetate Interaction
Unknowninteraction on record
Description
In a dedicated drug interaction trial, co-administration of ketoconazole, a strong inhibitor of CYP3A4, had no clinically meaningful effect on the pharmacokinetics of abiraterone [see Clinical Pharmacology ( 12.3 )].
Source: FDA drug label - abiraterone acetate